Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2010120387) OLIGOMER-PROTEIN TYROSINE KINASE INHIBITOR CONJUGATES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2010/120387 International Application No.: PCT/US2010/001163
Publication Date: 21.10.2010 International Filing Date: 19.04.2010
IPC:
A61K 47/48 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
48
the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Applicants:
RIGGS-SAUTHIER, Jennifer [US/US]; US (UsOnly)
ZHANG, Wen [US/US]; US (UsOnly)
NEKTAR THERAPEUTICS [US/US]; 455 Mission Bay Boulevard South Suite 100 San Francisco, CA 94158, US (AllExceptUS)
Inventors:
RIGGS-SAUTHIER, Jennifer; US
ZHANG, Wen; US
Agent:
WILSON, Mark A.; Nektar Therapeutics 455 Mission Bay Boulevard South Suite 100 San Francisco, CA 94158, US
Priority Data:
61/170,57017.04.2009US
61/267,30207.12.2009US
Title (EN) OLIGOMER-PROTEIN TYROSINE KINASE INHIBITOR CONJUGATES
(FR) CONJUGUÉS INHIBITEUR DE PROTÉINE TYROSINE KINASE-OLIGOMÈRE
Abstract:
(EN) The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water soluble, non peptidic oligomer.
(FR) L'invention concerne (entre autres) des conjugués inhibiteur de PTK-oligomère et des composés associés. Lorsqu'il est administré par une quelconque voie sélectionnée parmi un certain nombre de voies d'administration, un composé de l'invention présente des avantages sur des composés inhibiteurs de PTK dépourvus d'un oligomère non peptidique, soluble dans l'eau.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)